158 related articles for article (PubMed ID: 36546904)
1. Lung diffusion capacity correlates with pre-implant pulmonary hypertension and predicts outcome after LVAD implantation.
Macera F; Dewachter C; Stefanidis C; Vanden Eynden F; Bondue A; Vachiéry JL; Roussoulières A
ESC Heart Fail; 2023 Apr; 10(2):1043-1053. PubMed ID: 36546904
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Vascular Reverse Remodeling After Left Ventricular Assist Device Implantation in Patients With Pulmonary Hypertension.
Anegawa E; Seguchi O; Mochizuki H; Kuroda K; Doi Nakajima S; Watanabe T; Yanase M; Tadokoro N; Fukushima S; Fujita T; Fukushima N
ASAIO J; 2023 Feb; 69(2):151-158. PubMed ID: 36716069
[TBL] [Abstract][Full Text] [Related]
3. Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation.
Laimoud M; Hakami E; Maghirang MJ; Mohamed T
Egypt Heart J; 2023 Dec; 75(1):102. PubMed ID: 38117355
[TBL] [Abstract][Full Text] [Related]
4. Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcome.
Deis T; Balling L; Rossing K; Wolsk E; Perch M; Gustafsson F
ESC Heart Fail; 2019 Apr; 6(2):379-387. PubMed ID: 30784223
[TBL] [Abstract][Full Text] [Related]
5. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary function assessment post-left ventricular assist device implantation.
Sajgalik P; Kim CH; Stulak JM; Kushwaha SS; Maltais S; Joyce DL; Joyce LD; Johnson BD; Schirger JA
ESC Heart Fail; 2019 Feb; 6(1):53-61. PubMed ID: 30311748
[TBL] [Abstract][Full Text] [Related]
7. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
[TBL] [Abstract][Full Text] [Related]
8. The effect of left ventricular assist device therapy in patients with heart failure and mixed pulmonary hypertension.
Lim HS; Howell N; Ranasinghe A
Int J Artif Organs; 2017 Mar; 40(2):67-73. PubMed ID: 28315502
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
Ishihara S; Kioka H; Ohtani T; Asano Y; Yamaguchi O; Hikoso S; Toda K; Saito Y; Sawa Y; Yamauchi-Takihara K; Sakata Y
Pulm Circ; 2018; 8(3):2045894018770131. PubMed ID: 29575985
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
Ghio S; Crimi G; Temporelli PL; Traversi E; La Rovere MT; Cannito A; Vizza D; Scelsi L; Raineri C; Guazzi M; Oltrona Visconti L
Eur J Heart Fail; 2018 Apr; 20(4):725-734. PubMed ID: 29148140
[TBL] [Abstract][Full Text] [Related]
11. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
Mikus E; Stepanenko A; Krabatsch T; Loforte A; Dandel M; Lehmkuhl HB; Hetzer R; Potapov EV
Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
[TBL] [Abstract][Full Text] [Related]
12. Mechanical circulatory support restores eligibility for heart transplant in patients with significant pulmonary hypertension.
Biełka A; Kalinowski M; Hawranek M; Małyszek-Tumidajewicz J; Pacholewicz J; Kowalczuk-Wieteska A; Ratman K; Kubiak G; Król B; Przybyłowski P; Zembala M; Zembala MO
Kardiol Pol; 2020 Oct; 78(10):1008-1014. PubMed ID: 32692025
[TBL] [Abstract][Full Text] [Related]
13. Carbon Monoxide Diffusing Capacity Predicts Cardiac Readmission in Patients Undergoing Left Ventricular Assist Device Implantation in Japan.
Tsuji M; Amiya E; Bujo C; Hara T; Saito A; Minatsuki S; Maki H; Ishida J; Hosoya Y; Hatano M; Imai H; Nemoto M; Kagami Y; Endo M; Kimura M; Ando M; Shimada S; Kinoshita O; Ono M; Komuro I
ASAIO J; 2021 Oct; 67(10):1111-1118. PubMed ID: 33470633
[TBL] [Abstract][Full Text] [Related]
14. Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications.
Melenovsky V; Andersen MJ; Andress K; Reddy YN; Borlaug BA
Eur J Heart Fail; 2015 Nov; 17(11):1161-71. PubMed ID: 26467180
[TBL] [Abstract][Full Text] [Related]
15. Diffusion Capacity and Mortality in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
Hoeper MM; Meyer K; Rademacher J; Fuge J; Welte T; Olsson KM
JACC Heart Fail; 2016 Jun; 4(6):441-9. PubMed ID: 26874383
[TBL] [Abstract][Full Text] [Related]
16. Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.
Gupta S; Woldendorp K; Muthiah K; Robson D; Prichard R; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Dhital K; Granger E; Spratt P; Jansz P; Hayward CS
Heart Lung Circ; 2014 Oct; 23(10):963-9. PubMed ID: 24973864
[TBL] [Abstract][Full Text] [Related]
17. Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
Ibe T; Wada H; Sakakura K; Ugata Y; Maki H; Yamamoto K; Seguchi M; Taniguchi Y; Jinnouchi H; Momomura SI; Fujita H
PLoS One; 2021; 16(3):e0247987. PubMed ID: 33651852
[TBL] [Abstract][Full Text] [Related]
18. Phenotyping exercise limitation of patients with Interstitial Fibrosing Lung Disease: the importance of exercise hemodynamics.
Panagiotidou E; Βoutou A; Fouka E; Papakosta D; Chatzopoulos E; Sourla E; Markopoulou A; Kioumis I; Stanopoulos I; Pitsiou G
Pulmonology; 2024; 30(2):104-112. PubMed ID: 35568651
[TBL] [Abstract][Full Text] [Related]
19. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes.
Palazzini M; Dardi F; Manes A; Bacchi Reggiani ML; Gotti E; Rinaldi A; Albini A; Monti E; Galiè N
Eur J Heart Fail; 2018 Feb; 20(2):248-255. PubMed ID: 28464427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
